PDA Trial: Preterm Infant Patent Ductus Arteriosus: Expectant Management vs. Active Treatment

Expectant management for patent ductus arteriosus (PDA) in preterm infants did not lower risk of death or lung disease compared with active treatment. However, more infants survived in the expectant management group, according to results from…

Continue Reading